Attached files
| file | filename |
|---|---|
| EX-10.41 - EX-10.41 - SCICLONE PHARMACEUTICALS INC | scln-20151231ex10412e31a.htm |
| EX-10.40 - EX-10.40 - SCICLONE PHARMACEUTICALS INC | scln-20151231ex10404c96a.htm |
| EX-10.42 - EX-10.42 - SCICLONE PHARMACEUTICALS INC | scln-20151231ex10429b2e8.htm |
| 10-K - 10-K - SCICLONE PHARMACEUTICALS INC | scln-20151231x10k.htm |
| EX-32.1 - EX-32.1 - SCICLONE PHARMACEUTICALS INC | scln-20151231xex321.htm |
| EX-21.1 - EX-21.1 - SCICLONE PHARMACEUTICALS INC | scln-20151231xex211.htm |
| EX-31.2 - EX-31.2 - SCICLONE PHARMACEUTICALS INC | scln-20151231xex312.htm |
| EX-31.1 - EX-31.1 - SCICLONE PHARMACEUTICALS INC | scln-20151231xex311.htm |
| EX-32.2 - EX-32.2 - SCICLONE PHARMACEUTICALS INC | scln-20151231xex322.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S‑3 (Nos. 333-52471, 333-62309, 333-77543, 333-81481, 333-84487, 333-85673, 333-30938, 333-72800, 333-107538 and 333-176209) and Form S-8 (Nos. 333-145281, 333-128482, 333-120008, 333-109256, 033-66832, 333-98081, 333-45820, 333-62059, 333-12169, 333-168668, 333-183171 and 333-205554) of SciClone Pharmaceuticals, Inc. of our report dated March 11, 2016 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers Zhong Tian LLP
Shanghai, the People’s Republic of China
March 11, 2016